BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16568146)

  • 1. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When prostate brachytherapy fails: a case report and discussion.
    Kadoch C; D'Amico AV; Matthews RH
    Oncologist; 2005; 10(10):799-805. PubMed ID: 16314290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center.
    Lennernäs B; Holmäng S; Hedelin H
    Strahlenther Onkol; 2002 Oct; 178(10):537-41. PubMed ID: 12386784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid carcinoma after radiation treatment of prostatic adenocarcinoma.
    Huan Y; Idrees M; Gribetz ME; Unger PD
    Ann Diagn Pathol; 2008 Apr; 12(2):142-5. PubMed ID: 18325477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinosarcoma of the prostate: a case report].
    Yoshida T; Ujike T; Uemura M; Nin M; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2007 Nov; 53(11):817-9. PubMed ID: 18051809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?
    Canfield SE; Gans TH; Unger P; Hall SJ
    Tech Urol; 2001 Dec; 7(4):294-5. PubMed ID: 11763492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
    Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ
    J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Cancer; 2007 Aug; 110(3):551-5. PubMed ID: 17577217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.